Where the Comment is King

THE NEWS COMMENTER

VOTE  (0)  (0)

Moderna says its Covid vaccine is ‘well tolerated' in 6- to 11-year-olds after fears of heart inflammation in young adults

Added 10-25-21 11:37:03am EST - “Moderna Inc has claimed that its mRNA Covid vaccine is "well tolerated" in children between the ages of six to 11, and announced that the firm plans to submit the data from its study to regulatory bodies worldwide shortly.” - Rt.com

CLICK TO SHARE

Posted By TheNewsCommenter: From Rt.com: “Moderna says its Covid vaccine is ‘well tolerated’ in 6- to 11-year-olds after fears of heart inflammation in young adults”. Below is an excerpt from the article.

In a statement released on Monday, the company said its interim data from Phase 2/3 of the KidCOVE study showed the vaccine produced a “robust neutralizing antibody response.”

Healthy children between the ages of six and 11 participating in the study were given two doses, half the size of what adults receive, 28 days apart. According to the notice, the jab “was generally well tolerated with a safety and tolerability profile generally consistent with the Phase 3 COVE study in adolescents and adults.”

The majority of adverse events were mild or moderate, Moderna said, with the most common side effects documented including fatigue, headache, fever, and injection site pain.

Stephane Bancel, Chief Executive Officer of Moderna, said the company looks “forward to filing with regulators globally and [remains] committed to doing our part to help end the COVID-19 pandemic with a vaccine for adults and children of all ages.”

While recruitment is complete for the six to under 12 years cohort, which saw 4,753 subjects in this age group take part, the study “continues to enroll children [aged] six months to under six years of age.”

Read more...

If you don't see any comments yet, congrats! You get first comment. Be nice and have fun.

Comment Box is loading comments...

CLICK TO SHARE

BACK TO THE HOME-PAGE